Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 3 min ago

Pernix Therapeutics Announces Positive Phase IV Results of Silenor(R) vs. Zolpidem Head-to-Head Arousability Study

Thu, 06/16/2016 - 16:05
Data demonstrated that Pernix Therapeutics’ Silenor® 6 mg was superior to zolpidem 10 mg on all measures evaluated. Study results presented at SLEEP 2016 international meeting MORRISTOWN, N.J., June 16, 2016 -- (Healthcare Sales & Marketing Netwo...
Biopharmaceuticals
Pernix Therapeutics, Silenor, insomnia

Merck’s KEYTRUDA(R) (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer

Thu, 06/16/2016 - 15:58
KEYNOTE-024 Studied Patients Whose Tumors Expressed High Levels of PD-L1 KENILWORTH, N.J.--(Healthcare Sales & Marketing Network)--Merck (MRK), known as MSD outside the United States and Canada, today announced that the KEYNOTE-024 trial investigating t...
Biopharmaceuticals, Oncology
Merck, KEYTRUDA, pembrolizumab, Non-Small Cell Lung Cancer

United Kingdom's NHS Supply Chain to Acquire Seven TomoTherapy(R) Systems

Thu, 06/16/2016 - 15:55
Largest Ever Accuray Deal Will Provide More Cancer Patients in the United Kingdom (UK) Access to Advanced, Precise Radiation Treatments SUNNYVALE, Calif., June 16, 2016 -- (Healthcare Sales & Marketing Network) -- Accuray Incorporated (ARAY) has a sign...
Devices, Oncology
Accuray, TomoTherapy, radiosurgery, radiotherapy

Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System(R) for SI Joint Fusion

Wed, 06/15/2016 - 18:18
Plan Considers All Other SI Joint Fusion Products Experimental/Investigational and Not Covered SAN JOSE, Calif., June 15, 2016 -- (Healthcare Sales & Marketing Network) -- SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Impl...
Devices, Orthopaedic, Neurosurgery, Reimbursement
SI-BONE, iFuse Implant System, sacroiliac

BlueWind Medical Announces CE-Mark for the First in the World Miniature Wireless Neurostimulator to Treat Overactive Bladder

Wed, 06/15/2016 - 16:14
HERZLIYA, Israel, June 15, 2016 -- (Healthcare Sales & Marketing Network) -- Bluewind Medical, developer of a miniature wireless neurostimulation platform to treat multiple clinical indications, announced today that the company has received CE-Mark for it...
Devices, Urology, Neurology, Regulatory
BlueWind Medical, OAB-1000, Overactive Bladder, neurostimulator

Brett Reynolds Rejoins Cogentix Medical As Chief Financial Officer

Wed, 06/15/2016 - 16:11
MINNEAPOLIS, June 15, 2016 -- (Healthcare Sales & Marketing Network) -- Cogentix Medical, Inc. (CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today reported that Brett A. Rey...
Devices, Personnel
Cogentix Medical, EndoSheath, endoscopy

Allecra Therapeutics Announces €22 Million Series B Financing

Wed, 06/15/2016 - 13:11
Funding Supports Phase 2 Development of Novel Antibiotic to Treat Resistant Gram-negative Bacterial Infections in the Hospital LÖRRACH, Germany and SAINT LOUIS, France, June 15, 2016 -- (Healthcare Sales & Marketing Network) -- Allecra Therapeutic...
Biopharmaceuticals, Venture Capital
Allecra Therapeutics

German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit

Wed, 06/15/2016 - 13:03
Alimta Case Returned to Court of Appeal for New Ruling INDIANAPOLIS, June 14, 2016 -- (Healthcare Sales & Marketing Network) -- The German Federal Supreme Court has granted the appeal by Eli Lilly and Company (LLY) in the case of Eli Lilly and Company ...
Biopharmaceuticals, Generics, Litigation
Eli Lilly, Actavis, Alimta , pemetrexed

Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension

Tue, 06/14/2016 - 15:24
WEST COLUMBIA, S.C., June 14, 2016 -- (Healthcare Sales & Marketing Network) -- Nephron Pharmaceuticals Corporation (Nephron) launched generic Budesonide Inhalation Suspension yesterday. Nephron has licensed the Abbreviated New Drug Application from Apote...
Biopharmaceuticals, Generics, Drug Delivery, Product Launch
Nephron Pharmaceuticals, Budesonide, Pulmicort, asthma

Suneva Medical Closes $25 Million Financing To Support Continued Growth Opportunities

Tue, 06/14/2016 - 14:04
Financing includes $25 million equity investment from Essex Woodlands Growth equity firm's healthcare expertise key to further elevate Suneva Medical as an innovative aesthetics leader SAN DIEGO, June 14, 2016 -- (Healthcare Sales & Marketing Network...
Devices, Dermatology, Venture Capital
Suneva Medical, Bellafill, Regenica , dermal filler

Rivanna Medical Prepares for European Market Adoption of Accuro(TM) with the Appointment of New Vice President of Sales (EMEA)

Tue, 06/14/2016 - 13:56
Rivanna Medical Announces Receipt of CE Marking, and ISO 13485 Certification CHARLOTTESVILLE, VA--(Healthcare Sales & Marketing Network) - After recently launching international expansion in the Middle East, Rivanna Medical prepares for European Market ...
Devices, Personnel
Rivanna Medical, Accuro

Ability Dynamics, LLC. announces Distribution Partnership With Korean-Based Sunglim Trading Co.

Tue, 06/14/2016 - 13:50
TEMPE, Ariz., June 14, 2016 -- (Healthcare Sales & Marketing Network) -- Ability Dynamics, LLC an innovative developer of next-generation prosthetic devices announced a new exclusive distribution relationship with Korean-based Sunglim Trading Co. for its ...
Devices, Orthopaedic, Distribution
Ability Dynamics, Sunglim Trading

VitalConnect Announces Closure of $25 Million of Financing

Tue, 06/14/2016 - 13:42
Funding for growth of hospital and remote patient monitoring business SAN JOSE, Calif.--(Healthcare Sales & Marketing Network)--VitalConnect, a leader in medical-grade wearable biosensor systems, today announced that it has closed a term loan facility o...
Devices, Monitoring, Venture Capital
VitalConnect, wearable biosensor, HealthPatchMD VitalPatch

Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg

Mon, 06/13/2016 - 23:15
PHILADELPHIA, June 13, 2016 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (LCI) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Application (ANDA) for Neomycin...
Biopharmaceuticals, Generics, FDA
Lannett Company, Neomycin

Collegium Announces Election of John A. Fallon, M.D. to Board of Directors

Mon, 06/13/2016 - 23:12
CANTON, Mass., June 13, 2016 -- (Healthcare Sales & Marketing Network) -- Collegium Pharmaceutical, Inc. (COLL) today announced the election of John A. Fallon, M.D. to the Board of Directors. "John’s broad-based payer, managed care and physician gr...
Biopharmaceuticals, Drug Delivery, Personnel
Collegium Pharmaceutical, Xtampza, oxycodone

ContraVir Completes Merger with Ciclofilin Pharmaceuticals

Mon, 06/13/2016 - 15:28
Strengthens Hepatitis B Pipeline with Complementary Compound CPI-431-32 EDISON, N.J., June 13, 2016 -- (Healthcare Sales & Marketing Network) -- ContraVir Pharmaceuticals, Inc. (CTRV), a biopharmaceutical company focused on the development and commerci...
Biopharmaceuticals, Mergers & Acquisitions
ContraVir Pharmaceuticals, Ciclofilin Pharmaceuticals, antiviral

Walgreens Terminates Relationship with Theranos; Will Be Closing Operations at All 40 Theranos Wellness Centers in Arizona

Mon, 06/13/2016 - 15:26
Theranos laboratory testing services will no longer be offered through any Walgreens locations DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Walgreens today announced that it has informed Theranos that it will be terminating its relationship ...
Diagnostics, Distribution
Walgreens, Theranos

AiVita Biomedical Raises $2m in Series A Financing for Commercial and Clinical-Stage Program Development

Fri, 06/10/2016 - 16:21
California Technology Ventures backs AiVita Biomedical; Managing Director Alex Suh appointed to AiVita Board of Directors IRVINE, Calif., June 10, 2016 -- (Healthcare Sales & Marketing Network) -- AiVita Biomedical, a therapeutic development company fo...
Regenerative Medicine, Venture Capital, Personnel
AiVita Biomedical, stem cell

HeartStitch(R) Announces Top New Sales and Marketing VP Joins the HeartStitch Team

Fri, 06/10/2016 - 16:11
Highly Experienced Executive Will Fill Important Role of Vice President, International Sales and Marketing LOS ANGELES, CA--(Healthcare Sales & Marketing Network) - HeartStitch® is pleased to announce the appointment of Dirk Segers as Vice President...
Devices, Interventional, Cardiology, Personnel
HeartStitch, patent foramen ovale, PFO Closure

Galderma Celebrates 20th Global Anniversary of Restylane(R)

Fri, 06/10/2016 - 14:41
Restylane® Marks Heritage Milestone and Announces Innovative Syringe FORT WORTH, Texas, June 10, 2016 -- (Healthcare Sales & Marketing Network) -- Galderma, a global leader focused on medical solutions in skin health, is proud to celebrate the sign...
Biopharmaceuticals, Devices, Dermatology
Galderma, Restylane, dermal filler

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong